Skip to main content

3 Result(s)

within R Mesters Remove this filter Medicine & Public Health Remove this filter

and

  1. No Access

    Article

    Outcome of allogeneic stem cell transplantation for AML and myelodysplastic syndrome in elderly patients (⩾60 years)

    Allogeneic stem cell transplantation (SCT) remains the best curative option for patients with refractory AML or with high-risk myelodysplastic syndrome (MDS). For decades, age alone had been widely used as the...

    M Pohlen, C Groth, T Sauer, D Görlich, R Mesters… in Bone Marrow Transplantation (2016)

  2. No Access

    Article

    CD34+ lineage specific donor cell chimerism for the diagnosis and treatment of impending relapse of AML or myelodysplastic syndrome after allo-SCT

    After allo-SCT, analysis of CD34+ lineage-specific donor cell chimerism (DCC) is a sensitive method for monitoring minimal residual disease in patients with AML or myelodysplastic syndrome (MDS) with CD34 express...

    F Rosenow, A Berkemeier, U Krug, C Müller-Tidow, J Gerss… in Bone Marrow Transplantation (2013)

  3. No Access

    Chapter and Conference Paper

    Gerinnungsinhibitoren bei Sepsis und disseminierter intravasaler Gerinnung

    Eine grundlegende und für den deutschen Sprachraum prägende Definition der Sepsis geht auf H.Schottmüller zurück [68, 69]. Danach liegt eine Sepsis vor, „wenn sich innerhalb des Körpers ein Herd gebildet hat, von...

    J. Kienast, H. Ostermann, R. Mesters in Fachübergreifende Aspekte der Hämostaseologie (1994)